Home > > > > Report Detail

Covid-19 Impact on Global Transdermal Drug Delivery System Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 24-Apr-2020
No. of pages: 126
Inquire Before Buying

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 is about 31.1%. Transdermal Drug Delivery System can be used for OTC, Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion is about 83.3% in 2016.

North America is the largest sales place, with a revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place with the revenue market share of 28%. China and Japan are also important sales regions for Transdermal Drug Delivery System.

The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.

Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transdermal Drug Delivery System market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Transdermal Drug Delivery System industry.

Based on our recent survey, we have several different scenarios about the Transdermal Drug Delivery System YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 11620 million in 2019. The market size of Transdermal Drug Delivery System will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal Drug Delivery System market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal Drug Delivery System market in terms of revenue.

Players, stakeholders, and other participants in the global Transdermal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Transdermal Drug Delivery System market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Transdermal Drug Delivery System market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal Drug Delivery System market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal Drug Delivery System market.

The following players are covered in this report:

- Hisamitsu

- Mylan

- GSK

- Novartis

- Teve (Actavis)

- Johnson & Johnson

- Lohmann

- Teikoku Seiyaku

- Bayer

- Lingrui

- Sanofi

- Qizheng

- Endo

- Huarun 999

- Haw Par

- Nichiban

- Mentholatum

- Laboratoires Genevrier

Transdermal Drug Delivery System Breakdown Data by Type

- Fentanyl

- Nitroglycerin

- Estradiol

- Nicotine

- Other

Transdermal Drug Delivery System Breakdown Data by Application

- OTC

- Rx

Covid-19 Impact on Global Transdermal Drug Delivery System Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transdermal Drug Delivery System Revenue
1.4 Market Analysis by Type
1.4.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fentanyl
1.4.3 Nitroglycerin
1.4.4 Estradiol
1.4.5 Nicotine
1.4.6 Other
1.5 Market by Application
1.5.1 Global Transdermal Drug Delivery System Market Share by Application: 2020 VS 2026
1.5.2 OTC
1.5.3 Rx
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Drug Delivery System Industry Impact
1.6.1 How the Covid-19 is Affecting the Transdermal Drug Delivery System Industry
1.6.1.1 Transdermal Drug Delivery System Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transdermal Drug Delivery System Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transdermal Drug Delivery System Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Transdermal Drug Delivery System Market Perspective (2015-2026)
2.2 Transdermal Drug Delivery System Growth Trends by Regions
2.2.1 Transdermal Drug Delivery System Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transdermal Drug Delivery System Historic Market Share by Regions (2015-2020)
2.2.3 Transdermal Drug Delivery System Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Transdermal Drug Delivery System Market Growth Strategy
2.3.6 Primary Interviews with Key Transdermal Drug Delivery System Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery System Players by Market Size
3.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2015-2020)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2015-2020)
3.1.3 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transdermal Drug Delivery System Market Concentration Ratio
3.2.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2019
3.3 Transdermal Drug Delivery System Key Players Head office and Area Served
3.4 Key Players Transdermal Drug Delivery System Product Solution and Service
3.5 Date of Enter into Transdermal Drug Delivery System Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2015-2020)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2021-2026)
5 Transdermal Drug Delivery System Breakdown Data by Application (2015-2026)
5.1 Global Transdermal Drug Delivery System Market Size by Application (2015-2020)
5.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Transdermal Drug Delivery System Market Size (2015-2020)
6.2 Transdermal Drug Delivery System Key Players in North America (2019-2020)
6.3 North America Transdermal Drug Delivery System Market Size by Type (2015-2020)
6.4 North America Transdermal Drug Delivery System Market Size by Application (2015-2020)
7 Europe
7.1 Europe Transdermal Drug Delivery System Market Size (2015-2020)
7.2 Transdermal Drug Delivery System Key Players in Europe (2019-2020)
7.3 Europe Transdermal Drug Delivery System Market Size by Type (2015-2020)
7.4 Europe Transdermal Drug Delivery System Market Size by Application (2015-2020)
8 China
8.1 China Transdermal Drug Delivery System Market Size (2015-2020)
8.2 Transdermal Drug Delivery System Key Players in China (2019-2020)
8.3 China Transdermal Drug Delivery System Market Size by Type (2015-2020)
8.4 China Transdermal Drug Delivery System Market Size by Application (2015-2020)
9 Japan
9.1 Japan Transdermal Drug Delivery System Market Size (2015-2020)
9.2 Transdermal Drug Delivery System Key Players in Japan (2019-2020)
9.3 Japan Transdermal Drug Delivery System Market Size by Type (2015-2020)
9.4 Japan Transdermal Drug Delivery System Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Transdermal Drug Delivery System Market Size (2015-2020)
10.2 Transdermal Drug Delivery System Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transdermal Drug Delivery System Market Size by Type (2015-2020)
10.4 Southeast Asia Transdermal Drug Delivery System Market Size by Application (2015-2020)
11 India
11.1 India Transdermal Drug Delivery System Market Size (2015-2020)
11.2 Transdermal Drug Delivery System Key Players in India (2019-2020)
11.3 India Transdermal Drug Delivery System Market Size by Type (2015-2020)
11.4 India Transdermal Drug Delivery System Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Transdermal Drug Delivery System Market Size (2015-2020)
12.2 Transdermal Drug Delivery System Key Players in Central & South America (2019-2020)
12.3 Central & South America Transdermal Drug Delivery System Market Size by Type (2015-2020)
12.4 Central & South America Transdermal Drug Delivery System Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Hisamitsu
13.1.1 Hisamitsu Company Details
13.1.2 Hisamitsu Business Overview and Its Total Revenue
13.1.3 Hisamitsu Transdermal Drug Delivery System Introduction
13.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2015-2020))
13.1.5 Hisamitsu Recent Development
13.2 Mylan
13.2.1 Mylan Company Details
13.2.2 Mylan Business Overview and Its Total Revenue
13.2.3 Mylan Transdermal Drug Delivery System Introduction
13.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.2.5 Mylan Recent Development
13.3 GSK
13.3.1 GSK Company Details
13.3.2 GSK Business Overview and Its Total Revenue
13.3.3 GSK Transdermal Drug Delivery System Introduction
13.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.3.5 GSK Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview and Its Total Revenue
13.4.3 Novartis Transdermal Drug Delivery System Introduction
13.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Teve (Actavis)
13.5.1 Teve (Actavis) Company Details
13.5.2 Teve (Actavis) Business Overview and Its Total Revenue
13.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction
13.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.5.5 Teve (Actavis) Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
13.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction
13.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Lohmann
13.7.1 Lohmann Company Details
13.7.2 Lohmann Business Overview and Its Total Revenue
13.7.3 Lohmann Transdermal Drug Delivery System Introduction
13.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.7.5 Lohmann Recent Development
13.8 Teikoku Seiyaku
13.8.1 Teikoku Seiyaku Company Details
13.8.2 Teikoku Seiyaku Business Overview and Its Total Revenue
13.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction
13.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.8.5 Teikoku Seiyaku Recent Development
13.9 Bayer
13.9.1 Bayer Company Details
13.9.2 Bayer Business Overview and Its Total Revenue
13.9.3 Bayer Transdermal Drug Delivery System Introduction
13.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.9.5 Bayer Recent Development
13.10 Lingrui
13.10.1 Lingrui Company Details
13.10.2 Lingrui Business Overview and Its Total Revenue
13.10.3 Lingrui Transdermal Drug Delivery System Introduction
13.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2015-2020)
13.10.5 Lingrui Recent Development
13.11 Sanofi
10.11.1 Sanofi Company Details
10.11.2 Sanofi Business Overview and Its Total Revenue
10.11.3 Sanofi Transdermal Drug Delivery System Introduction
10.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.11.5 Sanofi Recent Development
13.12 Qizheng
10.12.1 Qizheng Company Details
10.12.2 Qizheng Business Overview and Its Total Revenue
10.12.3 Qizheng Transdermal Drug Delivery System Introduction
10.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.12.5 Qizheng Recent Development
13.13 Endo
10.13.1 Endo Company Details
10.13.2 Endo Business Overview and Its Total Revenue
10.13.3 Endo Transdermal Drug Delivery System Introduction
10.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.13.5 Endo Recent Development
13.14 Huarun 999
10.14.1 Huarun 999 Company Details
10.14.2 Huarun 999 Business Overview and Its Total Revenue
10.14.3 Huarun 999 Transdermal Drug Delivery System Introduction
10.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.14.5 Huarun 999 Recent Development
13.15 Haw Par
10.15.1 Haw Par Company Details
10.15.2 Haw Par Business Overview and Its Total Revenue
10.15.3 Haw Par Transdermal Drug Delivery System Introduction
10.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.15.5 Haw Par Recent Development
13.16 Nichiban
10.16.1 Nichiban Company Details
10.16.2 Nichiban Business Overview and Its Total Revenue
10.16.3 Nichiban Transdermal Drug Delivery System Introduction
10.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.16.5 Nichiban Recent Development
13.17 Mentholatum
10.17.1 Mentholatum Company Details
10.17.2 Mentholatum Business Overview and Its Total Revenue
10.17.3 Mentholatum Transdermal Drug Delivery System Introduction
10.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.17.5 Mentholatum Recent Development
13.18 Laboratoires Genevrier
10.18.1 Laboratoires Genevrier Company Details
10.18.2 Laboratoires Genevrier Business Overview and Its Total Revenue
10.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction
10.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2015-2020)
10.18.5 Laboratoires Genevrier Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Transdermal Drug Delivery System Key Market Segments
Table 2. Key Players Covered: Ranking by Transdermal Drug Delivery System Revenue
Table 3. Ranking of Global Top Transdermal Drug Delivery System Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fentanyl
Table 6. Key Players of Nitroglycerin
Table 7. Key Players of Estradiol
Table 8. Key Players of Nicotine
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Transdermal Drug Delivery System Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Transdermal Drug Delivery System Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Transdermal Drug Delivery System Players to Combat Covid-19 Impact
Table 15. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Transdermal Drug Delivery System Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Transdermal Drug Delivery System Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Transdermal Drug Delivery System Market Share by Regions (2015-2020)
Table 19. Global Transdermal Drug Delivery System Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Transdermal Drug Delivery System Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Transdermal Drug Delivery System Market Growth Strategy
Table 25. Main Points Interviewed from Key Transdermal Drug Delivery System Players
Table 26. Global Transdermal Drug Delivery System Revenue by Players (2015-2020) (Million US$)
Table 27. Global Transdermal Drug Delivery System Market Share by Players (2015-2020)
Table 28. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery System as of 2019)
Table 29. Global Transdermal Drug Delivery System by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Transdermal Drug Delivery System Product Solution and Service
Table 32. Date of Enter into Transdermal Drug Delivery System Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 35. Global Transdermal Drug Delivery System Market Size Share by Type (2015-2020)
Table 36. Global Transdermal Drug Delivery System Revenue Market Share by Type (2021-2026)
Table 37. Global Transdermal Drug Delivery System Market Size Share by Application (2015-2020)
Table 38. Global Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 39. Global Transdermal Drug Delivery System Market Size Share by Application (2021-2026)
Table 40. North America Key Players Transdermal Drug Delivery System Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Transdermal Drug Delivery System Market Share (2019-2020)
Table 42. North America Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 43. North America Transdermal Drug Delivery System Market Share by Type (2015-2020)
Table 44. North America Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 45. North America Transdermal Drug Delivery System Market Share by Application (2015-2020)
Table 46. Europe Key Players Transdermal Drug Delivery System Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Transdermal Drug Delivery System Market Share (2019-2020)
Table 48. Europe Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Transdermal Drug Delivery System Market Share by Type (2015-2020)
Table 50. Europe Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Transdermal Drug Delivery System Market Share by Application (2015-2020)
Table 52. China Key Players Transdermal Drug Delivery System Revenue (2019-2020) (Million US$)
Table 53. China Key Players Transdermal Drug Delivery System Market Share (2019-2020)
Table 54. China Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 55. China Transdermal Drug Delivery System Market Share by Type (2015-2020)
Table 56. China Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 57. China Transdermal Drug Delivery System Market Share by Application (2015-2020)
Table 58. Japan Key Players Transdermal Drug Delivery System Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Transdermal Drug Delivery System Market Share (2019-2020)
Table 60. Japan Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Transdermal Drug Delivery System Market Share by Type (2015-2020)
Table 62. Japan Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Transdermal Drug Delivery System Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Transdermal Drug Delivery System Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Transdermal Drug Delivery System Market Share (2019-2020)
Table 66. Southeast Asia Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Transdermal Drug Delivery System Market Share by Type (2015-2020)
Table 68. Southeast Asia Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Transdermal Drug Delivery System Market Share by Application (2015-2020)
Table 70. India Key Players Transdermal Drug Delivery System Revenue (2019-2020) (Million US$)
Table 71. India Key Players Transdermal Drug Delivery System Market Share (2019-2020)
Table 72. India Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 73. India Transdermal Drug Delivery System Market Share by Type (2015-2020)
Table 74. India Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 75. India Transdermal Drug Delivery System Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Transdermal Drug Delivery System Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Transdermal Drug Delivery System Market Share (2019-2020)
Table 78. Central & South America Transdermal Drug Delivery System Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Transdermal Drug Delivery System Market Share by Type (2015-2020)
Table 80. Central & South America Transdermal Drug Delivery System Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Transdermal Drug Delivery System Market Share by Application (2015-2020)
Table 82. Hisamitsu Company Details
Table 83. Hisamitsu Business Overview
Table 84. Hisamitsu Product
Table 85. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 86. Hisamitsu Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Product
Table 90. Mylan Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 91. Mylan Recent Development
Table 92. GSK Company Details
Table 93. GSK Business Overview
Table 94. GSK Product
Table 95. GSK Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 96. GSK Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Teve (Actavis) Company Details
Table 103. Teve (Actavis) Business Overview
Table 104. Teve (Actavis) Product
Table 105. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 106. Teve (Actavis) Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 111. Johnson & Johnson Recent Development
Table 112. Lohmann Company Details
Table 113. Lohmann Business Overview
Table 114. Lohmann Product
Table 115. Lohmann Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 116. Lohmann Recent Development
Table 117. Teikoku Seiyaku Business Overview
Table 118. Teikoku Seiyaku Product
Table 119. Teikoku Seiyaku Company Details
Table 120. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 121. Teikoku Seiyaku Recent Development
Table 122. Bayer Company Details
Table 123. Bayer Business Overview
Table 124. Bayer Product
Table 125. Bayer Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 126. Bayer Recent Development
Table 127. Lingrui Company Details
Table 128. Lingrui Business Overview
Table 129. Lingrui Product
Table 130. Lingrui Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 131. Lingrui Recent Development
Table 132. Sanofi Company Details
Table 133. Sanofi Business Overview
Table 134. Sanofi Product
Table 135. Sanofi Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 136. Sanofi Recent Development
Table 137. Qizheng Company Details
Table 138. Qizheng Business Overview
Table 139. Qizheng Product
Table 140. Qizheng Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 141. Qizheng Recent Development
Table 142. Endo Company Details
Table 143. Endo Business Overview
Table 144. Endo Product
Table 145. Endo Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 146. Endo Recent Development
Table 147. Huarun 999 Company Details
Table 148. Huarun 999 Business Overview
Table 149. Huarun 999 Product
Table 150. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 151. Huarun 999 Recent Development
Table 152. Haw Par Company Details
Table 153. Haw Par Business Overview
Table 154. Haw Par Product
Table 155. Haw Par Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 156. Haw Par Recent Development
Table 157. Nichiban Company Details
Table 158. Nichiban Business Overview
Table 159. Nichiban Product
Table 160. Nichiban Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 161. Nichiban Recent Development
Table 162. Mentholatum Company Details
Table 163. Mentholatum Business Overview
Table 164. Mentholatum Product
Table 165. Mentholatum Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 166. Mentholatum Recent Development
Table 167. Laboratoires Genevrier Company Details
Table 168. Laboratoires Genevrier Business Overview
Table 169. Laboratoires Genevrier Product
Table 170. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2015-2020) (Million US$)
Table 171. Laboratoires Genevrier Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery System Market Share by Type: 2020 VS 2026
Figure 2. Fentanyl Features
Figure 3. Nitroglycerin Features
Figure 4. Estradiol Features
Figure 5. Nicotine Features
Figure 6. Other Features
Figure 7. Global Transdermal Drug Delivery System Market Share by Application: 2020 VS 2026
Figure 8. OTC Case Studies
Figure 9. Rx Case Studies
Figure 10. Transdermal Drug Delivery System Report Years Considered
Figure 11. Global Transdermal Drug Delivery System Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Transdermal Drug Delivery System Market Share by Regions: 2020 VS 2026
Figure 13. Global Transdermal Drug Delivery System Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Transdermal Drug Delivery System Market Share by Players in 2019
Figure 16. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery System as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2019
Figure 18. North America Transdermal Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Transdermal Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Transdermal Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Transdermal Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Transdermal Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Transdermal Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Hisamitsu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 27. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 29. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 33. Teve (Actavis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 35. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 37. Lohmann Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 39. Teikoku Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 41. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 43. Lingrui Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 45. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 47. Qizheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 49. Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 51. Huarun 999 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 53. Haw Par Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 55. Nichiban Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 57. Mentholatum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 59. Laboratoires Genevrier Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs